Cargando…
Growth inhibition of human hepatocellular carcinoma cells by antagonism of the β(2) adrenergic receptor
Previous studies have shown that the activation of the β(2) adrenergic receptor (ADRB2) can stimulate several signaling pathways that promote tumor growth and metastasis. β-adrenergic antagonism may have a beneficial role in cancer treatment; however, little is known about the effect of ADRB2 inhibi...
Autores principales: | Dang, Dongmei, Zhang, Jing, Yang, Jianjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6036482/ https://www.ncbi.nlm.nih.gov/pubmed/30008820 http://dx.doi.org/10.3892/ol.2018.8847 |
Ejemplares similares
-
β2–Adrenergic Receptor Antagonism Attenuates CNV Through Inhibition of VEGF and IL-6 Expression
por: Lavine, Jeremy A., et al.
Publicado: (2017) -
β-arrestin2 regulating β2-adrenergic receptor signaling in hepatic stellate cells contributes to hepatocellular carcinoma progression
por: Li, Xiu-Qin, et al.
Publicado: (2021) -
G protein-coupled receptor kinase 2 regulating β2-adrenergic receptor signaling in M2-polarized macrophages contributes to hepatocellular carcinoma progression
por: Wu, Jing-Jing, et al.
Publicado: (2019) -
β-Adrenergic Receptor Antagonism of Cholinergic Stimulation of Airway Smooth Muscle Contraction: An Old Receptor Requires a Fresh Look
por: Leblanc, Normand
Publicado: (2023) -
INCREASED BETA2-ADRENERGIC RECEPTOR SIGNALING ENHANCES PROGRESSION OF HEPATOCELLULAR CARCINOMA
por: Pizzini, Jason, et al.
Publicado: (2019)